Bought
Maintained
Sold
Other funds holding HCM
AG
MGP
XC
CGH
Amundi's HCM Position: Q2 2026 in Review
Amundi reduced its HUTCHMED (HCM) stake by 12% in Q2 2026, selling an estimated $352K and leaving 204,385 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1160.
Amundi first reported a position in HCM in Q2 2021 and has held it in 21 quarters since. The position peaked at $11.4M in Q2 2021. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.
- Amundi held 204,385 shares of HUTCHMED worth $2.2M as of Q2 2026.
- Amundi sold 27,861 HUTCHMED shares in Q2 2026, an estimated $352K.
- HUTCHMED made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1160 holding.
- Amundi first reported a position in HUTCHMED in Q2 2021 and has held it in 21 quarters since.
- Amundi's HUTCHMED position peaked at $11.4M in Q2 2021.
- 56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.